Eli Lilly and Almirall report promising results from phase III atopic eczema study
![Photo: Mikkel Aabenhus Hemmingsen / MedWatch](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13917201.ece/ALTERNATES/schema-16_9/doc7kj2z8rywwk2na3vg8b.jpg)
Pharmaceutical giant Eli Lilly and Spanish dermatology company Almirall have come together to develop a treatment for atopic dermatitis, also known as atopic eczema.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
England and Wales reject Leo Pharma's eczema drug
For subscribers